Syngene Leadership Overhaul: CEO Change, KMS Executive Role

Syngene's Board approved Kiran Mazumdar Shaw's transition from Non-Executive to Executive Chairperson, effective April 1, 2026, for 5 years.
MD & CEO Peter Bains resigned, effective close of business June 30, 2026, ending his tenure at the company.
Siddharth Mittal, former MD & CEO of Biocon Limited, appointed as MD & CEO effective July 1, 2026, for 5 years.